ITBM Consulting

Serve as an interim product and technology executive for PE-backed and public-company clients, leading product strategy, platform modernization, operating transformation, and M&A value realization across healthcare, pharmacy, SaaS, and enterprise technology businesses. Clients include PSG, OptumRx, DaVitaRx, Galderma, WellMed, MedAssets, Aptia & Centene.

• Platform Scale & PE Exit: Spearheaded modernization of a legacy 340B TPA asset into a scalable cloud SaaS platform, migrating 50 B2B health systems, improving operational efficiency by >50%, and contributing to 5x valuation growth to $225M and a successful PE exit.

• P&L, Technology & Platform Leadership: Led enterprise technology, SaaS platform engineering, infrastructure, security, and operating P&L accountability; managed global teams, cloud providers, and a $30M partner/vendor ecosystem.

• Platform & Product-Led Growth: Architected and scaled data, analytics, and AI-powered products across value-based care, payer, pharmacy, and PBM platforms, unlocking net-new revenue streams and improving care-cost economics.

• M&A Value Realization: Led 5 complex M&A integrations, unifying enterprise architecture, business systems, and operating models to capture $100M revenue synergy tied to global market expansion.

• Compliance & Commercial Enablement: Rebuilt SOC 2 Type II compliance across two SaaS platforms, strengthening security and privacy controls, restoring enterprise trust, reducing churn risk, and unlocking $30M in net-new commercial revenue.

• Cost Optimization & Margin Expansion: Transformed clinical, pharmacy, and supply chain operations through technology-enabled workflow automation; reduced technology spend by 20% through build-vs-buy strategy, vendor rationalization, and commercial negotiations across a $30M partner ecosystem.